Explore
Definium Therapeutics, Inc.DFTX
$29.00-1.33%24H
DFTX / USDNASDAQ
Use arrow keys to change the interval
Equity Info
P/E Ratio—
Market Cap$4.51B
EPS-2.92
52 Week Range$10.46 - $49.70
Volume$61.91M
Liquidity Score—
About Definium Therapeutics, Inc.

Definium Therapeutics, Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company is headquartered in New York, New York.

HeadquartersNEW YORK, NY

Buy

—
—

Assets

Asset
Definium Therapeutics
rDFTX
Reality Finance
Trending
NVDA
NVIDIA Corporation
$158.281.83%
Details
QQQ
Invesco QQQ Trust Series 1
$657.980.15%
Details
SPY
SPDR S&P 500 ETF Trust
$732.070.04%
Details

Help